GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins
Year: 2020
Type: article
Source: Journal of Medicinal Chemistry
Institutions: GlaxoSmithKline (United Kingdom), GlaxoSmithKline (Germany)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3045004415
